Profil
Neil Smith has worked as a Director at Modulate Therapeutics, Inc. since 2015 and as Head-Operations and VP-Research & Development at Censa Pharmaceuticals, Inc. since 2016.
Aktive Positionen von Neil Smith
Unternehmen | Position | Beginn |
---|---|---|
Modulate Therapeutics, Inc.
Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | 01.01.2015 |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Geschäftsführer | 01.10.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Modulate Therapeutics, Inc.
Modulate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Modulate Therapeutics, Inc. develops a medicine compound designed to re-engage the immune system in order to recognize and eradicate neoplastic disease. The company was founded by September 29, 2015 and is headquartered in Montréal, Canada. | Health Technology |
Censa Pharmaceuticals, Inc.
Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA. | Health Technology |